Table 4.
Adjusted logistic regression of family planning process dependent variables
| Counseled on how to use, side effects, and when to returna | Counseled on method protection from STIb | ||||
|---|---|---|---|---|---|
| Variable | Category | OR | C.I. | OR | C.I. |
| Clients age (ref. = 14–24) | 25–39 | 0.7 | 0.4–1.3 | 0.7 | 0.4–1.4 |
| 40–58 & don’t know | 1.1 | 0.6–2.1 | 0.4* | 0.1–0.9 | |
| Client’s education (ref. = secondary or more) | No education | 0.5 | 0.3–1.1 | 0.5 | 0.2–1.3 |
| Primary & post primary | 1.0 | 0.5–1.8 | 1.1 | 0.4–2.7 | |
| Client status (ref. = returning client) | New client | 6.1*** | 3.7–10.2 | 5.3*** | 2.8–10.2 |
| Contraceptive method used (ref. = IUD or implants) | Pills | 0.6 | 0.3–1.4 | 1.2 | 0.4–3.4 |
| Progestin-only injection | 0.7 | 0.4–1.4 | 1.8 | 0.8–4.3 | |
| Provider category (ref. = midwife and other) | Nurse or nurse assistant | 0.8 | 0.4–1.4 | 1.4 | 0.6–3.3 |
| Provider years of education (ref. = 17+) | 6–12 | 1.6 | 0.4–7.1 | 0.3 | 0.1–2.0 |
| 13–16 | 1.2 | 0.7–2.2 | 1.2 | 0.6–2.7 | |
| Provider training in family planning in the past 24 months (ref. = no) | Yes | 1.5 | 0.8–2.7 | 0.8 | 0.4–1.9 |
| Provider activities supervised (ref. = none) | 1–5 | 0.6 | 0.3–1.4 | 0.8 | 0.3–2.6 |
| 6 | 0.7 | 0.4–1.6 | 1.4 | 0.6–3.6 | |
| Provider has a job description (ref. = no) | Yes | 0.9 | 0.4–1.8 | 1.4 | 0.6–2.9 |
| Provider salary type (ref. = none) | Monthly or daily salary | 1.9 | 0.5–6.4 | 9.0* | 1.4–58.0 |
| No regular salary but other compensation | 1.7 | 0.5–5.5 | 3.9 | 0.6–24.5 | |
| Health facility type (ref. = hospital/health center) | Health post | 1.6 | 0.9–2.9 | 1.0 | 0.4–2.4 |
| Locality (ref. = urban) | Rural | 0.8 | 0.4–1.6 | 4.0** | 1.4–11.6 |
| Region (ref. = Northern) | Dakar | 1.0 | 0.2–4.0 | 2.1 | 0.5–8.4 |
| Thiès | 1.9 | 0.6–6.1 | 2.0 | 0.4–9.1 | |
| Central | 0.9 | 0.3–3.1 | 1.1 | 0.2–5.4 | |
| East | 1.6 | 0.3–7.1 | 1.0 | 0.1–9.0 | |
| South | 0.8 | 0.2–2.8 | 1.8 | 0.5–7.2 | |
| General structure equipment composite index (ref. = low) | Medium | 1.8 | 0.7–4.7 | 0.5 | 0.2–1.3 |
| High | 1.9 | 0.8–4.5 | 0.5 | 0.2–1.3 | |
| Pseudo R2 | 0.17 | 0.19 | |||
aOnly applies to users of pill, injectable, IUD, and implant
bApplies to all users, only ten respondents reported using methods other than pill, injectable, IUD, or implant
*p < 0.05, **p < 0.01, ***p < 0.001
Note: Bold values indicate a p-value<0.05